The Metabolic Signature of AML Cells Treated With Homoharringtonine

Acute myeloid leukemia (AML) is a hematologic malignancy. The overall prognosis is poor and therapeutic strategies still need to be improved. Studies have found that abnormalities in metabolisms promote the survival of AML cells. In recent years, an increasing number of studies have reported the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yulong, Li, Na, Chang, Zhiguang, Wang, Huabin, Pei, Hanzhong, Zhang, Dengyang, Zhang, Qi, Huang, Junbin, Guo, Yao, Zhao, Yuming, Pan, Yihang, Chen, Chun, Chen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237253/
https://www.ncbi.nlm.nih.gov/pubmed/35774129
http://dx.doi.org/10.3389/fonc.2022.931527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237253/
https://www.ncbi.nlm.nih.gov/pubmed/35774129
http://dx.doi.org/10.3389/fonc.2022.931527

Ejemplares similares